Cogent Biosciences
COGT
COGT
39 hedge funds and large institutions have $33.7M invested in Cogent Biosciences in 2019 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 18 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less funds holding in top 10
Funds holding in top 10: →
61% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 18
71% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 17
Holders
39
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$841K | |
| 2 | +$227K | |
| 3 | +$137K | |
| 4 |
Jane Street
New York
|
+$132K |
| 5 |
Goldman Sachs
New York
|
+$111K |
Top Sellers
| 1 | -$2.2M | |
| 2 | -$946K | |
| 3 | -$406K | |
| 4 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$235K |
| 5 |
Bank of New York Mellon
New York
|
-$232K |